Estimating the Financial Impact of Gene Therapy
Wong, C. H.; Li, D.; Wang, N.; Gruber, J.; Conti, R.; Lo, A. W.
Show abstract
We assess the potential financial impact of future gene therapies by identifying the 109 late-stage gene therapy clinical trials currently underway, estimating the prevalence and incidence of their corresponding diseases, developing novel mathematical models of the increase in quality-adjusted life years for each approved gene therapy, and simulating the launch prices and the expected spending of these therapies over a 15-year time horizon. The results of our simulation suggest that an expected total of 1.09 million patients will be treated by gene therapy from January 2020 to December 2034. The expected peak annual spending on these therapies is $25.3 billion, and the total spending from January 2020 to December 2034 is $306 billion. We decompose their annual estimated spending by treated age group as a proxy for U.S. insurance type, and consider the tradeoffs of various methods of payment for these therapies to ensure patient access to their expected benefits.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Pricing Treatments Cost-Effectively When They Have Multiple Indications: Not Just a Simple Threshold Analysis 95%
- Multilevel and Quasi Monte Carlo methods for the calculation of the Expected Value of Partial Perfect Information 93%
- Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics 92%
Similar papers in this journal
- A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness under the Test-Negative Design: Analysis of Québec Administrative Data 94%
- Estimation of Vaccine Efficacy for Variants that Emerge After the Placebo Group Is Vaccinated 94%
- Network meta-analysis and random walks 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.